Breaking News

Thursday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
Organigram price target raised to C$6 from C$4 at Stifel » 11:34
04/15/21
04/15
11:34
04/15/21
11:34
OGI

Organigram

$2.57 /

-0.02 (-0.77%)

Stifel analyst Andrew…

Stifel analyst Andrew Partheniou raised the firm's price target on Organigram to C$6 from C$4 and keeps a Hold rating on the shares.

ShowHide Related Items >><<
OGI Organigram
$2.57 /

-0.02 (-0.77%)

OGI Organigram
$2.57 /

-0.02 (-0.77%)

04/14/21 Raymond James
Organigram price target lowered to C$5 from C$6 at Raymond James
04/14/21 Canaccord
Organigram price target raised to C$3.50 from C$2.00 at Canaccord
04/14/21 CIBC
CIBC downgrades Organigram to Underperformer with C$3.25 target
04/13/21 CIBC
Organigram downgraded to Underperformer from Neutral at CIBC
OGI Organigram
$2.57 /

-0.02 (-0.77%)

OGI Organigram
$2.57 /

-0.02 (-0.77%)

OGI Organigram
$2.57 /

-0.02 (-0.77%)

OGI Organigram
$2.57 /

-0.02 (-0.77%)

Wednesday
Recommendations
Organigram price target lowered to C$5 from C$6 at Raymond James » 10:39
04/14/21
04/14
10:39
04/14/21
10:39
OGI

Organigram

$2.67 /

-0.25 (-8.56%)

Raymond James analyst…

Raymond James analyst Rahul Sarugaser lowered the firm's price target on Organigram to C$5 from C$6 and keeps an Outperform rating on the shares.

ShowHide Related Items >><<
OGI Organigram
$2.67 /

-0.25 (-8.56%)

OGI Organigram
$2.67 /

-0.25 (-8.56%)

04/14/21 Canaccord
Organigram price target raised to C$3.50 from C$2.00 at Canaccord
04/14/21 CIBC
CIBC downgrades Organigram to Underperformer with C$3.25 target
04/13/21 CIBC
Organigram downgraded to Underperformer from Neutral at CIBC
OGI Organigram
$2.67 /

-0.25 (-8.56%)

OGI Organigram
$2.67 /

-0.25 (-8.56%)

OGI Organigram
$2.67 /

-0.25 (-8.56%)

OGI Organigram
$2.67 /

-0.25 (-8.56%)

Recommendations
Organigram price target raised to C$3.50 from C$2.00 at Canaccord » 07:22
04/14/21
04/14
07:22
04/14/21
07:22
OGI

Organigram

$2.92 /

+0.145 (+5.23%)

Canaccord analyst Matt…

Canaccord analyst Matt Bottomley raised the firm's price target on Organigram to C$3.50 from C$2.00 and keeps a Hold rating on the shares. The analyst noted its FQ2/21 results were well under expectations as the company's continued turnaround efforts were stifled by industry wide COVID-19 pressures and provincial inventory rightsizing efforts the he believes will weigh on most Canadian LP's in the early part of 2021.

ShowHide Related Items >><<
OGI Organigram
$2.92 /

+0.145 (+5.23%)

OGI Organigram
$2.92 /

+0.145 (+5.23%)

04/14/21 CIBC
CIBC downgrades Organigram to Underperformer with C$3.25 target
04/13/21 CIBC
Organigram downgraded to Underperformer from Neutral at CIBC
04/13/21 Alliance Global Partners
Organigram price target lowered to C$3.75 from C$4 at Alliance Global Partners
04/07/21 BMO Capital
Organigram upgraded to Market Perform from Underperform at BMO Capital
OGI Organigram
$2.92 /

+0.145 (+5.23%)

OGI Organigram
$2.92 /

+0.145 (+5.23%)

OGI Organigram
$2.92 /

+0.145 (+5.23%)

OGI Organigram
$2.92 /

+0.145 (+5.23%)

Downgrade
CIBC downgrades Organigram to Underperformer with C$3.25 target » 06:27
04/14/21
04/14
06:27
04/14/21
06:27
OGI

Organigram

$2.92 /

+0.145 (+5.23%)

CIBC analyst John Zamparo…

CIBC analyst John Zamparo downgraded Organigram to Underperformer from Neutral with a price target of C$3.25, down from C$5. It is s difficult to foresee Organigram returning to positive EBITDA, even in fiscal 2022, due to ongoing pandemic impacts, a pause in international sales, and declining domestic market share occurring at shrinking margins, Zamparo tells investors in a research note. The analyst assumes annual sales growth of 20%, about half that of consensus estimates.

ShowHide Related Items >><<
OGI Organigram
$2.92 /

+0.145 (+5.23%)

OGI Organigram
$2.92 /

+0.145 (+5.23%)

04/13/21 CIBC
Organigram downgraded to Underperformer from Neutral at CIBC
04/13/21 Alliance Global Partners
Organigram price target lowered to C$3.75 from C$4 at Alliance Global Partners
04/07/21 BMO Capital
Organigram upgraded to Market Perform from Underperform at BMO Capital
03/16/21 Stifel
Organigram price target raised to C$6 from C$1.90 at Stifel
OGI Organigram
$2.92 /

+0.145 (+5.23%)

OGI Organigram
$2.92 /

+0.145 (+5.23%)

OGI Organigram
$2.92 /

+0.145 (+5.23%)

OGI Organigram
$2.92 /

+0.145 (+5.23%)

Tuesday
Downgrade
Organigram downgraded to Underperformer from Neutral at CIBC » 21:33
04/13/21
04/13
21:33
04/13/21
21:33
OGI

Organigram

$2.92 /

+0.145 (+5.23%)

CIBC analyst John Zamparo…

CIBC analyst John Zamparo downgraded Organigram to Underperformer from Neutral with a C$3.25 price target.

ShowHide Related Items >><<
OGI Organigram
$2.92 /

+0.145 (+5.23%)

OGI Organigram
$2.92 /

+0.145 (+5.23%)

04/13/21 Alliance Global Partners
Organigram price target lowered to C$3.75 from C$4 at Alliance Global Partners
04/07/21 BMO Capital
Organigram upgraded to Market Perform from Underperform at BMO Capital
03/16/21 Stifel
Organigram price target raised to C$6 from C$1.90 at Stifel
03/15/21 BMO Capital
Organigram price target raised to C$4 from C$2 at BMO Capital
OGI Organigram
$2.92 /

+0.145 (+5.23%)

OGI Organigram
$2.92 /

+0.145 (+5.23%)

OGI Organigram
$2.92 /

+0.145 (+5.23%)

OGI Organigram
$2.92 /

+0.145 (+5.23%)

Recommendations
Organigram price target lowered to C$3.75 from C$4 at Alliance Global Partners » 16:17
04/13/21
04/13
16:17
04/13/21
16:17
OGI

Organigram

$2.92 /

+0.145 (+5.23%)

Alliance Global Partners…

Alliance Global Partners analyst Aaron Grey lowered the firm's price target on Organigram to C$3.75 from C$4 and keeps a Neutral rating on the shares following the company's weaker than expected fiscal Q2 results. Sales were impacted by COVID lockdowns as well as production constraints, resulting in Organigram's second quarter of sales declines, Grey tells investors in a research note. The analyst says "more tempered" near-term sales growth driving continued margin pressure keeps him on the sidelines.

ShowHide Related Items >><<
OGI Organigram
$2.92 /

+0.145 (+5.23%)

OGI Organigram
$2.92 /

+0.145 (+5.23%)

04/07/21 BMO Capital
Organigram upgraded to Market Perform from Underperform at BMO Capital
03/16/21 Stifel
Organigram price target raised to C$6 from C$1.90 at Stifel
03/15/21 BMO Capital
Organigram price target raised to C$4 from C$2 at BMO Capital
03/12/21 CIBC
Organigram price target raised to C$5 from C$4.25 at CIBC
OGI Organigram
$2.92 /

+0.145 (+5.23%)

OGI Organigram
$2.92 /

+0.145 (+5.23%)

OGI Organigram
$2.92 /

+0.145 (+5.23%)

OGI Organigram
$2.92 /

+0.145 (+5.23%)

Over a week ago
Downgrade
Fly Intel: Top five analyst downgrades » 09:54
04/09/21
04/09
09:54
04/09/21
09:54
CS

Credit Suisse

$10.63 /

-0.32 (-2.92%)

, BTI

British American Tobacco

$38.88 /

-0.9 (-2.26%)

, CHTR

Charter

$602.06 /

-13.08 (-2.13%)

, ATUS

Altice USA

$32.73 /

-0.495 (-1.49%)

, CHUY

Chuy's

$44.60 /

-2.89 (-6.09%)

Catch up on today's…

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Credit Suisse (CS) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Magdalena Stoklosa believing "lingering uncertainty" from the hedge fund loss will delay a re-rating in the shares. 2. British American Tobacco (BTI) downgraded to Neutral from Overweight at JPMorgan with analyst Celine Pannuti saying the company is entering an investment ramp-up phase that is likely to hold back earnings growth over the medium term. 3. Charter (CHTR) downgraded to Neutral from Buy at Citi with analyst Michael Rollins saying three recent developments give the analyst pause regarding future broadband growth for cable firms: faster annual fiber upgrades, wireless home broadband ambitions, and risks from government policy direction. 4. Altice USA (ATUS) downgraded to Neutral from Buy at Citi with analyst Michael Rollins saying consensus for average broadband net adds between 2022 and 2025 "seems too robust and may need to be cut by more than half." 5. Chuy's (CHUY) downgraded to Hold from Buy at Stifel with analyst Chris O'Cull citing valuation for the downgrade following the stock's recent rally. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
CS Credit Suisse
$10.63 /

-0.32 (-2.92%)

CHUY Chuy's
$44.60 /

-2.89 (-6.09%)

CHTR Charter
$602.06 /

-13.08 (-2.13%)

BTI British American Tobacco
$38.88 /

-0.9 (-2.26%)

ATUS Altice USA
$32.73 /

-0.495 (-1.49%)

CS Credit Suisse
$10.63 /

-0.32 (-2.92%)

04/09/21 Morgan Stanley
Credit Suisse downgraded to Equal Weight from Overweight at Morgan Stanley
04/07/21 RBC Capital
Credit Suisse price target lowered to CHF 11 from CHF 14.50 at RBC Capital
04/07/21 Exane BNP Paribas
Credit Suisse downgraded to Neutral from Outperform at Exane BNP Paribas
04/06/21 JPMorgan
JPMorgan downgrades Credit Suisse to Neutral, sees shares to trade at discount
BTI British American Tobacco
$38.88 /

-0.9 (-2.26%)

04/09/21 JPMorgan
British American Tobacco downgraded to Neutral from Overweight at JPMorgan
04/07/21 BMO Capital
Organigram upgraded to Market Perform from Underperform at BMO Capital
03/26/21
Fly Intel: Top five analyst upgrades
03/26/21 Jefferies
British American Tobacco upgraded to Buy from Hold at Jefferies
CHTR Charter
$602.06 /

-13.08 (-2.13%)

04/09/21 Citi
Charter downgraded to Neutral from Buy at Citi
03/16/21 Wells Fargo
Wells starts Charter at Overweight on margin expansion potential
03/16/21 Wells Fargo
Charter initiated with an Overweight at Wells Fargo
03/01/21 TD Securities
Liberty Broadband upgraded to Buy at TD Securities after Charter pullback
ATUS Altice USA
$32.73 /

-0.495 (-1.49%)

04/09/21 Citi
Altice USA downgraded to Neutral from Buy at Citi
03/16/21 Wells Fargo
Altice USA started at Equal Weight at Wells Fargo on balanced valuation
03/16/21 Wells Fargo
Altice USA initiated with an Equal Weight at Wells Fargo
02/12/21 Pivotal Research
Altice USA earnings selloff a buying opportunity, says Pivotal Research
CHUY Chuy's
$44.60 /

-2.89 (-6.09%)

04/09/21 Stifel
Chuy's downgraded to Hold from Buy at Stifel
03/05/21 Stephens
Chuy's price target raised to $44 from $32 at Stephens
02/25/21 BMO Capital
Chuy's downgraded to Market Perform from Outperform at BMO Capital
02/10/21 Raymond James
Chuy's downgraded to Market Perform at Raymond James on valuation
CS Credit Suisse
$10.63 /

-0.32 (-2.92%)

CHUY Chuy's
$44.60 /

-2.89 (-6.09%)

CHTR Charter
$602.06 /

-13.08 (-2.13%)

ATUS Altice USA
$32.73 /

-0.495 (-1.49%)

  • 13
    Aug
  • 23
    Jun
  • 06
    May
CS Credit Suisse
$10.63 /

-0.32 (-2.92%)

CHTR Charter
$602.06 /

-13.08 (-2.13%)

CS Credit Suisse
$10.63 /

-0.32 (-2.92%)

CHTR Charter
$602.06 /

-13.08 (-2.13%)

BTI British American Tobacco
$38.88 /

-0.9 (-2.26%)

ATUS Altice USA
$32.73 /

-0.495 (-1.49%)

CS Credit Suisse
$10.63 /

-0.32 (-2.92%)

Downgrade
British American Tobacco downgraded to Neutral from Overweight at JPMorgan » 05:59
04/09/21
04/09
05:59
04/09/21
05:59
BTI

British American Tobacco

$39.78 /

+1.14 (+2.95%)

JPMorgan analyst Celine…

JPMorgan analyst Celine Pannuti downgraded British American Tobacco to Neutral from Overweight with a price target of 3,100 GBp, down from 3,500 GBp. Heated tobacco products are an integral part of the global nicotine industry's future and British American is still at the investment stage, Dinges tells investors in a research note. The company is entering an investment ramp-up phase that is likely to hold back earnings growth over the medium term, says the analyst.

ShowHide Related Items >><<
BTI British American Tobacco
$39.78 /

+1.14 (+2.95%)

BTI British American Tobacco
$39.78 /

+1.14 (+2.95%)

04/07/21 BMO Capital
Organigram upgraded to Market Perform from Underperform at BMO Capital
03/26/21
Fly Intel: Top five analyst upgrades
03/26/21 Jefferies
British American Tobacco upgraded to Buy from Hold at Jefferies
03/18/21 Barclays
British American Tobacco price target raised to 3,800 GBp from 3,300 GBp at Barclays
BTI British American Tobacco
$39.78 /

+1.14 (+2.95%)

On The Fly
Rising High: Canopy Growth to acquire The Supreme Cannabis Company in $435M deal » 12:09
04/08/21
04/08
12:09
04/08/21
12:09
CGC

Canopy Growth

$29.27 /

-0.63 (-2.11%)

, SPRWF

Supreme Cannabis

$0.00 /

+ (+0.00%)

, OGI

Organigram

$3.22 /

+0.075 (+2.38%)

, AGFAF

Agraflora Organics

$0.00 /

+ (+0.00%)

, TCNNF

Trulieve Cannabis

$0.00 /

+ (+0.00%)

, VRNOF

Verano Holdings

$0.00 /

+ (+0.00%)

, FFNTF

4Front Ventures

$0.00 /

+ (+0.00%)

, PLNHF

Planet 13 Holdings

$0.00 /

+ (+0.00%)

, APHA

Aphria

$16.54 /

+0.33 (+2.04%)

, TLRY

Tilray

$20.17 /

+0.42 (+2.13%)

, ACB

Aurora Cannabis

$8.62 /

+0.21 (+2.50%)

, CVSI

CV Sciences

$0.00 /

+ (+0.00%)

, CTST

CannTrust

$0.64 /

+ (+0.00%)

, CRON

Cronos Group

$8.86 /

+0.15 (+1.72%)

, CAN

Canaan

$19.00 /

+0.4 (+2.15%)

, IGC

India Globalization Capital

$1.70 /

-0.015 (-0.87%)

, ZYNE

Zynerba

$4.36 /

+0.015 (+0.35%)

, BTI

British American Tobacco

$39.64 /

+1 (+2.59%)

In this week's "Rising…

ShowHide Related Items >><<
VRNOF Verano Holdings
$0.00 /

+ (+0.00%)

TCNNF Trulieve Cannabis
$0.00 /

+ (+0.00%)

SPRWF Supreme Cannabis
$0.00 /

+ (+0.00%)

PLNHF Planet 13 Holdings
$0.00 /

+ (+0.00%)

OGI Organigram
$3.22 /

+0.075 (+2.38%)

IGC India Globalization Capital
$1.70 /

-0.015 (-0.87%)

CTST CannTrust
$0.64 /

+ (+0.00%)

CGC Canopy Growth
$29.27 /

-0.63 (-2.11%)

CAN Canaan
$19.00 /

+0.4 (+2.15%)

BTI British American Tobacco
$39.64 /

+1 (+2.59%)

APHA Aphria
$16.54 /

+0.33 (+2.04%)

AGFAF Agraflora Organics
$0.00 /

+ (+0.00%)

CGC Canopy Growth
$29.27 /

-0.63 (-2.11%)

04/09/21 Stifel
Supreme Cannabis downgraded to Sell from Buy at Stifel
04/09/21 Cantor Fitzgerald
Canopy Growth price target lowered to C$35 from C$62 at Cantor Fitzgerald
04/08/21 Alliance Global Partners
Canopy Growth price target lowered to C$40 from C$60 at Alliance Global Partners
04/06/21 MKM Partners
Canopy Growth price target raised to C$55 from C$28 at MKM Partners
SPRWF Supreme Cannabis
$0.00 /

+ (+0.00%)

04/09/21 Stifel
Supreme Cannabis downgraded to Sell from Buy at Stifel
03/10/21 BMO Capital
Supreme Cannabis upgraded to Outperform from Market Perform at BMO Capital
02/16/21 Stifel
Supreme Cannabis price target raised to C$0.55 from C$0.20 at Stifel
OGI Organigram
$3.22 /

+0.075 (+2.38%)

04/07/21 BMO Capital
Organigram upgraded to Market Perform from Underperform at BMO Capital
03/16/21 Stifel
Organigram price target raised to C$6 from C$1.90 at Stifel
03/15/21 BMO Capital
Organigram price target raised to C$4 from C$2 at BMO Capital
03/12/21 CIBC
Organigram price target raised to C$5 from C$4.25 at CIBC
AGFAF Agraflora Organics
$0.00 /

+ (+0.00%)

TCNNF Trulieve Cannabis
$0.00 /

+ (+0.00%)

03/29/21 Stifel
Stifel says New York adult use cannabis market represents $5B opportunity
03/25/21 Stifel
Trulieve Cannabis price target raised to C$118 from C$107 at Stifel
03/24/21 Canaccord
Trulieve Cannabis price target raised to C$87 from C$75 at Canaccord
03/24/21 Cantor Fitzgerald
Trulieve Cannabis price target raised to $84 from $70 at Cantor Fitzgerald
VRNOF Verano Holdings
$0.00 /

+ (+0.00%)

03/12/21 Canaccord
Verano Holdings initiated with a Speculative Buy at Canaccord
FFNTF 4Front Ventures
$0.00 /

+ (+0.00%)

PLNHF Planet 13 Holdings
$0.00 /

+ (+0.00%)

04/06/21 Northland
Planet 13 Holdings price target raised to $7 from $5.50 at Northland
11/25/20 Canaccord
Planet 13 Holdings price target raised to C$6.50 from C$6 at Canaccord
11/25/20 Northland
Planet 13 Holdings price target raised to $5.50 from $4 at Northland
11/23/20 Canaccord
Planet 13 Holdings price target raised to C$6 from C$5.50 at Canaccord
APHA Aphria
$16.54 /

+0.33 (+2.04%)

04/08/21 Alliance Global Partners
Aphria price target raised to $26 from $20 at Alliance Global Partners
04/06/21 Stifel
Aphria price target raised to C$22 from C$15.50 at Stifel
02/22/21 CIBC
Aphria price target raised to C$28 from C$18 at CIBC
TLRY Tilray
$20.17 /

+0.42 (+2.13%)

02/18/21
Fly Intel: Top five analyst downgrades
02/18/21 Roth Capital
Tilray price target raised to $25 from $10 at Roth Capital
ACB Aurora Cannabis
$8.62 /

+0.21 (+2.50%)

04/05/21 CIBC
Aurora Cannabis price target lowered to C$15 from C$18.50 at CIBC
02/16/21 CIBC
Aurora Cannabis price target raised to C$18.50 from C$17 at CIBC
02/16/21 GLJ Research
Aurora Cannabis shares have 100% downside by end of 2022, says GLJ Research
CVSI CV Sciences
$0.00 /

+ (+0.00%)

03/19/21 Piper Sandler
CV Sciences downgraded to Neutral on 'modest' growth at Piper Sandler
03/18/21 Piper Sandler
CV Sciences downgraded to Neutral from Overweight at Piper Sandler
02/02/21 Craig-Hallum
Legalization could drive '3x upside' for U.S. cannabis stocks, says Craig-Hallum
CTST CannTrust
$0.64 /

+ (+0.00%)

CRON Cronos Group
$8.86 /

+0.15 (+1.72%)

03/01/21 Canaccord
Cronos Group price target raised to C$7.50 from C$6.50 at Canaccord
02/22/21 CIBC
Cronos Group downgraded to Neutral from Outperformer at CIBC
CAN Canaan
$19.00 /

+0.4 (+2.15%)

IGC India Globalization Capital
$1.70 /

-0.015 (-0.87%)

01/29/21 Stifel
'Goldilocks' scenario for U.S. cannabis industry in play, says Stifel
12/04/20 Alliance Global Partners
Alliance Global sees low odds of MORE Act passing this congressional session
ZYNE Zynerba
$4.36 /

+0.015 (+0.35%)

03/10/21 Roth Capital
Zynerba price target lowered to $7.25 from $8.00 at Roth Capital
02/03/21 Ladenburg
Jazz deal for GW 'spotlights' value of Zynerba CBD products, says Ladenburg
BTI British American Tobacco
$39.64 /

+1 (+2.59%)

04/09/21
Fly Intel: Top five analyst downgrades
04/09/21 JPMorgan
British American Tobacco downgraded to Neutral from Overweight at JPMorgan
03/26/21
Fly Intel: Top five analyst upgrades
ZYNE Zynerba
$4.36 /

+0.015 (+0.35%)

VRNOF Verano Holdings
$0.00 /

+ (+0.00%)

TLRY Tilray
$20.17 /

+0.42 (+2.13%)

TCNNF Trulieve Cannabis
$0.00 /

+ (+0.00%)

OGI Organigram
$3.22 /

+0.075 (+2.38%)

CRON Cronos Group
$8.86 /

+0.15 (+1.72%)

CGC Canopy Growth
$29.27 /

-0.63 (-2.11%)

APHA Aphria
$16.54 /

+0.33 (+2.04%)

ACB Aurora Cannabis
$8.62 /

+0.21 (+2.50%)

  • 22
    Jan
  • 11
    Nov
SPRWF Supreme Cannabis
$0.00 /

+ (+0.00%)

CTST CannTrust
$0.64 /

+ (+0.00%)

CGC Canopy Growth
$29.27 /

-0.63 (-2.11%)

TCNNF Trulieve Cannabis
$0.00 /

+ (+0.00%)

SPRWF Supreme Cannabis
$0.00 /

+ (+0.00%)

OGI Organigram
$3.22 /

+0.075 (+2.38%)

FFNTF 4Front Ventures
$0.00 /

+ (+0.00%)

CGC Canopy Growth
$29.27 /

-0.63 (-2.11%)

CAN Canaan
$19.00 /

+0.4 (+2.15%)

ZYNE Zynerba
$4.36 /

+0.015 (+0.35%)

TLRY Tilray
$20.17 /

+0.42 (+2.13%)

OGI Organigram
$3.22 /

+0.075 (+2.38%)

IGC India Globalization Capital
$1.70 /

-0.015 (-0.87%)

CRON Cronos Group
$8.86 /

+0.15 (+1.72%)

CGC Canopy Growth
$29.27 /

-0.63 (-2.11%)

CAN Canaan
$19.00 /

+0.4 (+2.15%)

APHA Aphria
$16.54 /

+0.33 (+2.04%)

ACB Aurora Cannabis
$8.62 /

+0.21 (+2.50%)

Upgrade
Organigram upgraded to Market Perform from Underperform at BMO Capital » 20:34
04/07/21
04/07
20:34
04/07/21
20:34
OGI

Organigram

$3.15 /

-0.14 (-4.26%)

, BTI

British American Tobacco

$38.64 /

-0.075 (-0.19%)

BMO Capital analyst Tamy…

BMO Capital analyst Tamy Chen upgraded Organigram (OGI) to Market Perform from Underperform with an unchanged C$4.00 price target. The analyst is positive on the company's strategic collaboration with British American Tobacco (BTI), adjusting his target multiple to 10-times forward revenue from 4.5-times. Chen adds that the sector has been soft over the past few weeks, which is not surprising following the post-U.S. election rally.

ShowHide Related Items >><<
OGI Organigram
$3.15 /

-0.14 (-4.26%)

BTI British American Tobacco
$38.64 /

-0.075 (-0.19%)

OGI Organigram
$3.15 /

-0.14 (-4.26%)

03/16/21 Stifel
Organigram price target raised to C$6 from C$1.90 at Stifel
03/15/21 BMO Capital
Organigram price target raised to C$4 from C$2 at BMO Capital
03/12/21 CIBC
Organigram price target raised to C$5 from C$4.25 at CIBC
03/12/21 Raymond James
Organigram price target raised to C$6 from C$3 at Raymond James
BTI British American Tobacco
$38.64 /

-0.075 (-0.19%)

03/26/21
Fly Intel: Top five analyst upgrades
03/26/21 Jefferies
British American Tobacco upgraded to Buy from Hold at Jefferies
03/18/21 Barclays
British American Tobacco price target raised to 3,800 GBp from 3,300 GBp at Barclays
03/16/21 Citi
Last U.S. cigarette smoker like to quit by 2050, says Citi
OGI Organigram
$3.15 /

-0.14 (-4.26%)

OGI Organigram
$3.15 /

-0.14 (-4.26%)

OGI Organigram
$3.15 /

-0.14 (-4.26%)

OGI Organigram
$3.15 /

-0.14 (-4.26%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.